Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis

Phase: N/A Priority: Normal
NCT ID: NCT04105699 Org: User:
Start: 12/10/19 End: 12/28/23 Due: 12/28/24

Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.

Phase: N/A Priority: Normal
NCT ID: NCT05627076 Org: User:
Start: 08/29/22 End: 10/31/22 Due: 10/31/23

abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies

Phase: N/A Priority: Normal
NCT ID: NCT04442932 Org: User:
Start: 11/15/20 End: 03/15/21 Due: 03/15/22

Prospective Study to Validate the Diagnostic Performance of IVD CAPSULE COVID-19-NP Test for the Detection of SARS-CoV-2

Phase: N/A Priority: Normal
NCT ID: NCT05596032 Org: User:
Start: 10/23/22 End: 02/01/23 Due: 02/01/24

Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population

Phase: N/A Priority: Normal
NCT ID: NCT04409561 Org: User:
Start: 11/15/21 End: 01/15/22 Due: 01/15/23

Analytical Validation of the abioSCOPE Device With an IgE Test Panel: Point-of-Care Precision, Sample Type Comparison and Method Correlation

Phase: N/A Priority: Normal
NCT ID: NCT04401631 Org: User:
Start: 11/30/20 End: 12/31/20 Due: 12/31/21

Early Diagnostic of Sepsis and Potential Impact on Antibiotic Management Based on Serial.Pancreatic Stone Protein (PSP) Measured Using the AbioScope.

Phase: N/A Priority: Normal
NCT ID: NCT03474809 Org: User:
Start: 06/14/18 End: 03/15/19 Due: 03/15/20

abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003

Phase: N/A Priority: Normal
NCT ID: NCT05849935 Org: User:
Start: 07/17/23 End: 07/31/23 Due: 07/31/24